Treatment of hepatitis induced by anti-tuberculosis drugs (experimental research)
Introduction: Tuberculosis is a widely spread infection. While treating patients for it, they are given simultaneously and for a long period 5-6 antibacterial drugs, which are, as a rule, bad for the liver. It quite often (up to 20%) causes drug-induced hepatitis. As experi...
Main Authors: | Vladimir N. Fedorov, Nikolai A. Smirnov, Vladimir P. Vdovichenko, Tatyana B. Fedorova, Edgar E. Kerbenev, Aleksei K. Petrovsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2020-09-01
|
Series: | Research Results in Pharmacology |
Online Access: | https://rrpharmacology.pensoft.net/article/56453/download/pdf/ |
Similar Items
-
Selank and semax as potential hepatoprotectors in medical treatment of tuberculosis
by: Alexey K. Petrovsky, et al.
Published: (2019-12-01) -
Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity
by: Mohammed A. Agha, et al.
Published: (2015-01-01) -
Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.
by: Nino Lomtadze, et al.
Published: (2013-01-01) -
Drug-induced complications of anti-tuberculosis drugs in HIV patients
by: Rasoulinejad M, et al.
Published: (2011-01-01) -
Application of Anti-Tuberculosis Drug-Metabolising Enzyme Inhibition and Polymorphisms Improve Anti-Tuberculosis Drug-Induced Hepatotoxicity
by: Tung-Yuan Shih, et al.
Published: (2013)